Back to TARSView Full Landscape
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
2 competitors in Persistent Corneal Epithelial Defect
KPRXKIO-201, a Crosslinked Thiolated Carboxymethyl Hyaluronic Acid 0.75% (CMHA-S)
Phase 2KPRXKIO-201, a Crosslinked Thiolated Carboxymethyl Hyaluronic Acid (CMHA-S)
Phase 2Drug Information
Target Indication
Persistent Corneal Epithelial Defect
Clinical Trial
NCT07886268Last updated: 10/21/2026
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Developer
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts